Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 20;11(19):5512.
doi: 10.3390/jcm11195512.

Nephrolithiasis: A Red Flag for Cardiovascular Risk

Affiliations
Review

Nephrolithiasis: A Red Flag for Cardiovascular Risk

Alessia Gambaro et al. J Clin Med. .

Abstract

Epidemiological evidence shows that nephrolithiasis is associated with cardiovascular (CV) morbidities. The association between nephrolithiasis and CV disease is not surprising because both diseases share conditions that facilitate their development. Metabolic conditions, encompassed in the definition of metabolic syndrome (MS), and habits that promote nephrolithiasis by altering urine composition also promote clinical manifestations of CV disease. By inducing oxidative stress, these conditions cause endothelial dysfunction and increased arterial stiffness, which are both well-known predictors of CV disease. Furthermore, the subtle systemic metabolic acidosis observed in stone formers with CV disease may have a pathogenic role by increasing bone turnover and leading to reduced mineral content and osteoporosis/osteopenia. Heart valves and/or coronary artery and aortic calcifications are frequently associated with reduced mineral density. This is known as the 'calcification paradox' in osteoporosis and has also been observed in subjects with calcium nephrolithiasis. Evidence supports the hypothesis that osteoporosis/osteopenia is an independent risk factor for the development of CV calcifications. In the long term, episodes of renal stones may occur from the onset of metabolic derangements/MS to arterial stiffness/atherosclerosis and CV morbidities. These episodes should be considered a warning sign of an ongoing and silent atherosclerotic process. The evaluation of cardiometabolic risk factors and MS components should be routine in the assessment of renal stone formers. This would allow for treatment and prevention of the development of CV complications, which are much more severe for the patient and for public health.

Keywords: calcification paradox; cardiovascular risk; ectopic calcification; hypertension; metabolic syndrome; nephrolithiasis; osteoporosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Nephrolithiasis and CV risk factors.
Figure 2
Figure 2
Temporal relationship between MS, stone episodes and CV events.

References

    1. Geraghty R.M., Jones P., Somani B.K. Worldwide Trends of Urinary Stone Disease Treatment Over the Last Two Decades: A Systematic Review. J. Endourol. 2017;31:547–556. doi: 10.1089/end.2016.0895. - DOI - PubMed
    1. Abufaraj M., Xu T., Cao C., Waldhoer T., Seitz C., D’Andrea D., Siyam A., Tarawneh R., Fajkovic H., Schernhammer E., et al. Prevalence and Trends in Kidney Stone Among Adults in the USA: Analyses of National Health and Nutrition Examination Survey 2007–2018 Data. Eur. Urol. Focus. 2021;7:1468–1475. doi: 10.1016/j.euf.2020.08.011. - DOI - PubMed
    1. Taylor E.N., Stampfer M.J., Curhan G.C. Obesity, Weight Gain, and the Risk of Kidney Stones. JAMA. 2005;293:455–462. doi: 10.1001/jama.293.4.455. - DOI - PubMed
    1. Taylor E.N., Stampfer M.J., Curhan G.C. Diabetes Mellitus and the Risk of Nephrolithiasis. Kidney Int. 2005;68:1230–1235. doi: 10.1111/j.1523-1755.2005.00516.x. - DOI - PubMed
    1. West B., Luke A., Durazo-Arvizu R.A., Cao G., Shoham D., Kramer H. Metabolic Syndrome and Self-Reported History of Kidney Stones: The National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am. J. Kidney Dis. 2008;51:741–747. doi: 10.1053/j.ajkd.2007.12.030. - DOI - PubMed

LinkOut - more resources